Skip to main content
. 2022 Sep 2;14(17):3628. doi: 10.3390/nu14173628

Table 2.

Visual analogue scale (VAS) scores at W0, W4, and W12.

W0 W4 W12 p-Value
LMM
Values Value Difference
(95% CI)
p-Value 1 Values Difference
(95% CI)
p-Value 1
6AA Placebo 6AA Placebo 6AA Placebo
VAS1 Pain 38.0 33.1 30.0 32.7 −7.6 0.0001 * 19.7 26.9 −12.2 0.0123 * 0.0023 *
(22.2) (20.2) (20.6) (20.7) (−11.1 to −4.2) (20.1) (17.6) (−21.6 to −2.8)
Discomfort 38.7 34.8 28.6 34.4 −9.7 0.0001 * 19.3 27.6 −12.2 0.0121 * 0.0040 *
(22.7) (20.9) (21.0) (21.7) (−14.3 to −5.0) (18.9) (18.2) (−21.5 to −2.8)
Stiffness 35.5 30.6 27.8 29.8 −7.0 0.0023 * 19.6 25.9 −11.3 0.0250 * 0.0055 *
(24.8) (20.2) (21.6) (19.7) (−11.3 to −2.6) (18.5) (18.0) (−21.2 to −1.5)
VAS2 Pain 46.1 42.0 34.6 41.2 −10.8 0.0004 * 25.4 34.6 −13.4 0.0059 * 0.0024 *
(22.4) (22.4) (23.3) (22.0) (−16.5 to −5.0) (22.3) (20.5) (−22.7 to −4.0)
Discomfort 44.6 41.3 34.0 41.2 −10.4 0.0003 * 24.4 33.9 −12.8 0.0093 * 0.0041 *
(24.3) (22.1) (24.1) (22.1) (−15.8 to −5.1) (22.7) (19.4) (−22.2 to −3.3)
Stiffness 45.5 39.0 35.1 39.6 −11.0 0.0001 * 25.2 33.8 −15.1 0.0019 * 0.0006 *
(24) (21.7) (24.7) (21.6) (−16.1 to −5.9) (22.0) (21.5) (−24.4 to −5.9)
VAS3 Pain 50.9 47.4 38.4 45.4 −10.4 0.0001 * 26.8 36.4 −13.2 0.0105 * 0.0046 *
(21.4) (21.5) (22.1) (21.5) (−15.3 to −5.6) (20.6) (21.4) (−23.1 to −3.2)
Discomfort 50.3 46.8 37.2 45.6 −11.9 <0.0001 * 26.2 36.3 −13.6 0.0072 * 0.0034 *
(21.8) (21.5) (22.3) (20.6) (−16.9 to −6.9) (18.7) (21.8) (−23.3 to −3.9)
Stiffness 48.7 42.4 36.5 42.0 −11.7 <0.0001 * 26.5 34.9 −14.7 0.0022 * 0.0006 *
(22.0) (22.3) (22.2) (21.4) (−16.7 to −6.8) (18.7) (22.6) (−23.9 to −5.6)
VAS4 Pain 37.3 30.4 25.5 31.6 −13.0 <0.0001 * 19.2 26.4 −14.1 0.0025 * 0.0012 *
(23.1) (19.1) (19.9) (22.3) (−18.1 to −7.9) (18.5) (16.8) (−23.0 to −5.2)
Discomfort 39.4 30.9 26.8 32.0 −13.8 <0.0001 * 20.2 27.2 −15.6 0.0011 * 0.0003 *
(22.8) (22.7) (19.9) (24.1) (−18.2 to −9.4) (19.6) (19.1) (−24.6 to −6.5)
Stiffness 38.5 30.0 26.5 30.0 −12.0 <0.0001 * 19.9 26.0 −14.6 0.0037 * 0.0006 *
(23.8) (21.8) (20.4) (22.1) (−16.4 to −7.6) (19.2) (19.0) (−24.2 to −5.0)
VAS5 Pain 40.5 39.3 30.4 41.2 −11.9 <0.0001 * 22.9 33.2 −11.5 0.0131 * 0.0083 *
(21.5) (20.6) (21.5) (20.9) (−16.4 to −7.4) (20.1) (19.5) (−20.4 to −2.5)
Discomfort 41.3 39.7 29.3 41.1 −13.3 <0.0001 * 22.1 33.6 −13.1 0.0074 * 0.0042 *
(22.5) (21.0) (21.1) (21.2) (−18.5 to −8.2) (19.1) (20.2) (−22.5 to −3.7)
Stiffness 39.1 37.8 28.4 39.7 −12.6 <0.0001 * 21.8 32.7 −12.1 0.0112 * 0.0059 *
(21.8) (22.3) (21.5) (21.0) (−16.6 to −8.5) (19.1) (20.4) (−21.4 to −2.9)
VAS6 Pain 44.9 44.5 35.8 44.9 −9.5 <0.0001 * 26.5 36.3 −10.2 0.0228 * 0.0131 *
(22.1) (19.3) (20.2) (19.6) (−13.1 to −5.8) (20.9) (19.9) (−18.9 to −1.5)
Discomfort 45.0 44.4 34.6 44.8 −10.8 <0.0001 * 26.0 36.1 −10.8 0.0166 * 0.0101 *
(22.5) (19.9) (20.3) (20.2) (−14.5 to −7.1) (20.3) (20.2) (−19.5 to −2.0)
Stiffness 43.5 40.8 33.7 42.9 −11.9 <0.0001 * 26.2 34.8 −11.2 0.0128 * 0.0088 *
(23.4) (22.0) (20.9) (21.2) (−15.8 to −8.0) (20.5) (21.0) (−20.0 to −2.5)
VAS7 Pain 23.8 17.3 15.7 19.1 −10.0 0.0002 * 11.0 17.4 −12.9 0.0005 * 0.0001 *
(20.7) (19.0) (16.0) (20.3) (−14.9 to −5.0) (12.5) (17.4) (−19.8 to −6.0)
Discomfort 24.1 16.2 15.8 19.5 −11.6 <0.0001 * 11.5 17.4 −13.8 0.0006 * 0.0001 *
(20.9) (19.6) (16.4) (21.1) (−16.7 to −6.5) (12.9) (17.8) (−21.3 to −6.2)
Stiffness 23.1 16.0 15.6 18.7 −10.2 <0.0001 * 11.6 17.3 −12.8 0.0008 * 0.0001 *
(20.7) (18.9) (16.9) (20.5) (−14.7 to −5.8) (12.8) (17.7) (−19.9 to −5.6)
VAS8 Pain 45.1 36.3 31.1 35.2 −12.9 <0.0001 * 24.3 30.0 −14.6 0.0018 * 0.0010 *
(20.8) (21.0) (17.9) (20.1) (−18.1 to −7.7) (18.6) (18.2) (−23.4 to −5.7)
Discomfort 47.2 37.2 30.6 37.1 −16.4 <0.0001 * 22.2 31.1 −18.8 0.0001 * <0.0001 *
(20.5) (21.5) (17.3) (19.6) (−22.0 to −10.8) (15.8) (19.3) (−27.8 to −9.9)
Stiffness 43.8 34.1 29.4 34.3 −14.6 <0.0001 * 21.7 29.3 −17.3 0.0001 * <0.0001 *
(20.8) (21.4) (17.0) (20.1) (−20.1 to −9.0) (15.2) (19.2) (−25.7 to −9.0)

Data are presented as mean ± SD. 1 CI, confidence interval; LMM, linear mixed model; SD, standard deviation; W, week. The differences between the 6AA and control groups in changes from W0 to W4 and W12 were assessed by Student’s t-test * p < 0.05 between the 6AA and placebo groups. VAS scores were obtained for pain, discomfort, or stiffness experienced during eight different activities. These were as follows: VAS1, walking up stairs; VAS2, walking down stairs; VAS3, standing up from a chair; VAS4, kneeling (‘seiza’ in Japanese); VAS5, standing from seiza; VAS6, getting out of bed upon waking; VAS7, at rest before bed; and VAS8, walking a long distance or for a longer time than usual.